Almost a million people inoculated with Chinese COVID-19 vaccine — firm

Latest News

Almost a million people inoculated with Chinese COVID-19 vaccine — firm

Friday, November 20, 2020

Print this page Email A Friend!


BEIJING, China (AFP) — Nearly a million people have taken an experimental coronavirus vaccine developed by Chinese company Sinopharm, the firm said, although it has not yet provided any clear clinical evidence of efficacy.

China has been giving experimental COVID-19 vaccines to people including state employees, international students and essential workers heading abroad since July.

Sinopharm's chairman told media this week that nearly a million people have now received their vaccine for emergency use, though he did not provide a specific figure.

"We have not received a single report of severe adverse reaction, and only a few had some mild symptoms," Liu Jingzhen said in an interview re-published by the state-owned firm on Wednesday.

China has been bullish about the development of its vaccine for the new virus — which first emerged in the centre of the country late last year — with four vaccines now in late-stage testing.

Many of the trials are taking place overseas, as China has largely brought the virus under control within its borders.

Sinopharm is testing two vaccines in late-stage trials in countries including the UAE, Bahrain, Egypt, Jordan, Peru and Argentina.

The company claimed this week to be "leading the world in all aspects" of vaccine development, although it did not offer clinical evidence from ongoing trials.

Instead it cited anecdotal experiences from those who have been inoculated, including "construction personnel, diplomats, and overseas students" who it said have gone on to visit more than 150 countries after vaccination without being infected.

President Xi Jinping has declared that any Chinese vaccine would be a "global public good", after the country came under criticism, particularly from the US, for its early handling of the outbreak.

Many who have been inoculated in China are not formal participants in drugmakers' trials and are said to have done so voluntarily.

Competition has intensified among pharmaceutical companies racing to develop a COVID-19 shot, with two vaccines — one by US company Pfizer and its German partner BioNTech, and another by US firm Moderna — publishing large-scale trial data this month that showed their jabs were around 95 percent effective against COVID-19.


Now you can read the Jamaica Observer ePaper anytime, anywhere. The Jamaica Observer ePaper is available to you at home or at work, and is the same edition as the printed copy available at http://bit.ly/epaper-login


ADVERTISEMENT




POST A COMMENT

HOUSE RULES

1. We welcome reader comments on the top stories of the day. Some comments may be republished on the website or in the newspaper � email addresses will not be published.

2. Please understand that comments are moderated and it is not always possible to publish all that have been submitted. We will, however, try to publish comments that are representative of all received.

3. We ask that comments are civil and free of libellous or hateful material. Also please stick to the topic under discussion.

4. Please do not write in block capitals since this makes your comment hard to read.

5. Please don't use the comments to advertise. However, our advertising department can be more than accommodating if emailed: advertising@jamaicaobserver.com.

6. If readers wish to report offensive comments, suggest a correction or share a story then please email: community@jamaicaobserver.com.

7. Lastly, read our Terms and Conditions and Privacy Policy



comments powered by Disqus
ADVERTISEMENT

Poll

ADVERTISEMENT
ADVERTISEMENT

Today's Cartoon

Click image to view full size editorial cartoon
ADVERTISEMENT